Alkem Laboratories has informed that, with reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has enclosed herewith press release and analyst presentation on Q4FY17 & FY17 earnings and business updates and the same will be uploaded on the website of the Company.
The above information is a part of company’s filings submitted to BSE.